Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study

Soham D. Puvvada, José M. Guillén-Rodríguez, Jessica Yan, Lora Inclán, Kara Heard, Xavier I. Rivera, Faiz Anwer, Daruka Mahadevan, Jonathan H. Schatz, Daniel O. Persky

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study'. Together they form a unique fingerprint.

Medicine & Life Sciences